Literature DB >> 19070747

Melanotic neuroectodermal tumor of infancy: 2 decades of clinical experience with 18 patients.

Amit Chaudhary1, Ashish Wakhlu, Neetu Mittal, Sanjeev Misra, Divya Mehrotra, A K Wakhlu.   

Abstract

PURPOSE: The purpose of this article is to report our experience in the management of 18 patients with melanotic neuroectodermal tumor of infancy involving the maxillary alveolus. PATIENTS AND METHODS: All patients presented with hard nontender swelling involving the upper alveolus with facial deformity. Analysis included hematocrit, coagulation profile, serum creatinine, and screening for vanillyl mandelic acid and catecholamines. Imaging studies included x-ray of the maxilla and chest, ultrasound of the abdomen, computed tomography scan (1990 to 1999), and magnetic resonance imaging (after 1999). All surgeries were performed using endotracheal anesthesia, and complete gross excision of the tumor was achieved with coverage of the defect with mucoperiosteal flaps. All specimens were subjected to histopathology and immunohistochemistry.
RESULTS: The expansion of the alveolus produced by the tumor improved in 4 to 6 months. Subsequent dentition was affected by the removal of involved tooth buds during the operation. All the patients are in regular follow-up (maximum 206 months) and there has been no local recurrence or distant metastasis. Mean follow-up time was 130.8 months (95% confidence interval, 168.8-210.6). Overall survival at 17 years was 85.6%. Median survival could not be established due to statistically insignificant sample size, while mean survival time was 189.7 months (95% confidence interval, 103.7-157.8).
CONCLUSIONS: In the absence of metastatic disease, melanotic neuroectodermal tumors of infancy can be successfully managed by local excision.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19070747     DOI: 10.1016/j.joms.2007.04.027

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  7 in total

1.  Mandibular melanotic neuroectodermal tumor of infancy: a role for neoadjuvant chemotherapy.

Authors:  Christopher Maroun; Ibrahim Khalifeh; Elie Alam; Pierre Abi Akl; Raya Saab; Roger V Moukarbel
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-23       Impact factor: 2.503

2.  Melanotic neuroectodermal tumour of infancy - A rare entity.

Authors:  Neelam Noel Andrade; Paul C Mathai; Vyankatesh Sahu; Neha Aggarwal; Tanvi Andrade
Journal:  J Oral Biol Craniofac Res       Date:  2016-07-25

3.  Melanotic Neuroectodermal Tumor Presenting as Endolymphatic Sac Tumor.

Authors:  Joseph Choy; Mehdi Abouzari; Hossein Mahboubi; Mark E Linskey; Hamid R Djalilian
Journal:  Ear Nose Throat J       Date:  2019-04-07       Impact factor: 1.697

4.  Melanotic neuroectodermal tumor of infancy: A rare case report with differential diagnosis and review of the literature.

Authors:  Balaji Babu Bangi; M L Avinash Tejasvi
Journal:  Contemp Clin Dent       Date:  2012-01

5.  Melanotic neuroectodermal tumor of infancy in ovary: A rare case report.

Authors:  Zan Liu; Ming Li; Xianglian Tang; Yaling Xiao; Zhenghui Xiao; Yong Li
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

Review 6.  Clinical and imaging features of melanotic neuro-ectodermal tumor of infancy of the maxillary bone: report of four cases and review of the literature.

Authors:  Yujiao Guo; Ying Liu; Xingang Wang; Gang Li; Guoxia Yu
Journal:  Oral Radiol       Date:  2022-07-25       Impact factor: 1.882

7.  Melanotic neuroectodermal tumor of infancy in the maxilla.

Authors:  Daniel Falbo Martins de Souza; Daniel Isaac Sendyk; Juliana Seo; Eduardo Vasques da Fonseca; Maria da Graça Naclério-Homem; Maria Cristina Zindel Deboni
Journal:  Case Rep Dent       Date:  2013-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.